Death receptor 3 and Tl1a: A driving force in osteoclast differentiation and potential target for rheumatoid arthritis therapy [Abstract]

Collins, Fraser, Stone, Michael D., Wang, Edward Chung Yern ORCID: https://orcid.org/0000-0002-2243-4964 and Williams, Anwen Sian ORCID: https://orcid.org/0000-0001-6118-020X 2012. Death receptor 3 and Tl1a: A driving force in osteoclast differentiation and potential target for rheumatoid arthritis therapy [Abstract]. Rheumatology 51 (s3) , p. 140. 10.1093/rheumatology/kes108

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI)
Subjects:	R Medicine > RC Internal medicine R Medicine > RM Therapeutics. Pharmacology
Publisher:	Oxford University Press
ISSN:	1462-2567
Last Modified:	24 Oct 2022 10:14
URI:	https://orca.cardiff.ac.uk/id/eprint/43509

Actions (repository staff only)

Edit Item